COMPLETEDNA

HRQOL of Life After ECMO Due to COVID-19.

Health-related Quality of Life Following Extracorporeal Membrane Oxygenation Due to Coronavirus Disease 2019.

NCT05531032•Medical University of Vienna

Summary

We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•patients surviving COVID-19 ARDS and ECMO therapy

Exclusion Criteria

•no consent

Locations (1)

Medical University of Vienna

Vienna, Austria

Key Dates

Start Date

August 30, 2022

Primary Completion Date

October 31, 2024

Completion Date

October 31, 2024

Last Updated

April 13, 2025

Enrollment

44

ACTUAL participants

Conditions

ARDSCOVID-19 PneumoniaExtracorporeal Membrane Oxygenation

Interventions

Phone Interview

OTHER

Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation

NCT07414056

Acute Respiratory Distress Syndrome (ARDS)

View study

RECRUITINGNA

Platform of Randomized Adaptive Clinical Trials in Critical Illness

NCT05440851

Respiratory InsufficiencyExtracorporeal Membrane Oxygenation Complication+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITINGPHASE2